Potential role of rivaroxaban in patients with acute coronary syndrome

about

Potential role of rivaroxaban in patients with acute coronary syndrome

Item

http://www.wikidata.org/entity/Q36433688

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Potential role of rivaroxaban in patients with acute coronary syndrome

@ast

Potential role of rivaroxaban in patients with acute coronary syndrome

@en

type

Item

label

Potential role of rivaroxaban in patients with acute coronary syndrome

@ast

Potential role of rivaroxaban in patients with acute coronary syndrome

@en

prefLabel

Potential role of rivaroxaban in patients with acute coronary syndrome

@ast

Potential role of rivaroxaban in patients with acute coronary syndrome

@en

P1476

Potential role of rivaroxaban in patients with acute coronary syndrome

@en

P2093

David H Fitchett

http://www.w3.org/2001/XMLSchema#string

P2860

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

Warfarin and aspirin versus aspirin alone in patients with acute myocardial infarction: a pilot study

Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators

Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery

Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization

Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial

P304

349-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/DDDT.S30342

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23209364

http://www.w3.org/2001/XMLSchema#string

P932

3509996

http://www.w3.org/2001/XMLSchema#string